A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Sichuan Kelun-Biotech Biopharmaceutical discovers new ADCs targeting CDH3
Sichuan Kelun-Biotech Biopharmaceutical discovers new ADCs targeting CDH3
Insilico Medicine presents new KIF18A inhibitors
Insilico Medicine presents new KIF18A inhibitors
Holiday notice
Holiday notice
In the clinic for Feb. 13, 2026
In the clinic for Feb. 13, 2026
Other news to note for Feb. 13, 2026
Other news to note for Feb. 13, 2026
Regulatory actions for Feb. 13, 2026
Regulatory actions for Feb. 13, 2026
Money raised by biopharma
Money raised by biopharma
Biopharma money raised: Jan. 1-Feb. 12, 2026
Biopharma money raised: Jan. 1-Feb. 12, 2026
Quantx raises $85M to advance oral immunology drugs
Quantx raises $85M to advance oral immunology drugs
NME Digest: Q4 2025
NME Digest: Q4 2025
New CBL-B inhibitors reported in Aurigene Oncology patent
New CBL-B inhibitors reported in Aurigene Oncology patent
Nanjing Anji Biotechnology synthesizes new OGDH inhibitors
Nanjing Anji Biotechnology synthesizes new OGDH inhibitors
Salubris Pharma divulges new dual ETA/AT1 antagonists
Salubris Pharma divulges new dual ETA/AT1 antagonists
Financings for Feb. 12, 2026
Financings for Feb. 12, 2026
In the clinic for Feb. 12, 2026
In the clinic for Feb. 12, 2026
Other news to note for Feb. 12, 2026
Other news to note for Feb. 12, 2026
Regulatory actions for Feb. 12, 2026
Regulatory actions for Feb. 12, 2026
Abbvie claims CMS’ selection of Botox violates the IRA
Abbvie claims CMS’ selection of Botox violates the IRA
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page